IBS Pain Relief Medication
A new IBS Pain Relief Medication with diarrhea seems to reduce symptoms for some patients for at least six months, two clinical trials found.Based on these findings, the drug Viberzi (eluxadoline) was approved recently by the U.S. Food and Drug Administration.
In the phase 3 trials, more than 30 percent of patients experienced improvement in their symptoms at least half of the time they were taking the drug. This compared to about a 20 percent improvement in those taking a placebo, the study authors said.
“This IBS Pain Relief Medication offers another option for patients who have IBS (irritable bowel syndrome) with diarrhea who have not found relief with currently available treatment,” said lead researcher Dr. Anthony Lembo, an associate professor of medicine at Harvard Medical School in Boston